1,644
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Structural Docking Studies of COX-II Inhibitory Activity for Metabolites Derived from Corchorus olitorius and Vitis vinifera

, , , &
Pages 2377-2384 | Received 21 Jul 2015, Accepted 27 Oct 2015, Published online: 24 Jun 2016

REFERENCES

  • Herschman, H.R. Prostaglandin Synthase 2. Biochimica et Biophysica Acta 1996, 1299, 125–140.
  • Seibert, K.; Zhang, Y.; Leahy, K.; Hauser, S.; Masferrer, J.; Perkins, W.; Lee, L.; Isakon, P. Pharmacological and Biochemical Demonstration of the Role Of Cyclooxygenase 2 in Inflammation and Pain. Proceedings of the National Academy of Sciences of the United States of America, 1994, 91, 12013–12017.
  • Masferrer, J.L.; Zweifel, B.S.; Manning, P.T.; Hauser, S.D.; Leahy, K.M.; Smith, W.G.; Isakson, P.C.; Seiber, K. Selective Inhibition of Inducible Cyclooxygenase 2 in Vivo Is Anti-inflammatory And Nonulcerogenic. Proceedings of the National Academy of Sciences of the United States of America, 1994, 91, 3228–3232.
  • Kurumbail, R.G.; Stevens, A.M.; Gierse, J.K.; McDonald, J.J.; Steqeman, R.A.; Pak, J.Y.; Gildehaus, D.; Miyashiro, J.M.; Penning, T.D.; Seibert, K.; Isakson, P.C.; Stallings, W.C. Structural Basis for Selective Inhibition of Cyclooxygenase-2 by Anti-Inflammatory Agents. Nature 1996, 384, 644–648.
  • Laneuville, O.; Breuer, D.K.; Dewitt, D.L.; Hla, T.; Funk, C.D.; Smith, W.L. Differential Inhibition of Human Prostaglandin Endoperoxide H Synthases-1 and -2 By Nonsteroidal Anti-Inflammatory Drugs. Journal of Pharmacology and Experimental Therapeutics 1994, 271, 927–934.
  • Mitchell, J.A.; Akarasereenont, P.; Thiemermann, C.; Flower, R.J.; Vane, J.R. Selectivity of Nonsteroidal Antiinflammatory Drugs As Inhibitors of Constitutive and Inducible Cyclooxygenase. Proceedings of the National Academy of Sciences of the United States of America 1993, 90, 11693–11697.
  • Lin, C.; Li, C.; Shih, Y.; Chuang, L. Antioxidant and Anti-Inflammatory Properties of Lower-Polymerized Polyphenols in Oolong Tea. International Journal of Food Properties 2014, 16, 752–764.
  • Asanuma, M.; Miyazaki, I. Nonsteroidal Anti-Inflammatory Drugs in Experimental Parkinsonian Models and Parkinson’s Disease. Current Pharmaceutical Design 2008, 14, 1428–1434.
  • Katalinic, V.; Mozina, S.; Generalic, I.; Skroza, D.; Ljubenkov, I.; Klancnik, A. Phenolic Profile, Antioxidant Capacity, and Antimicrobial Activity of Leaf Extracts from Six Vitis Vinifera L. Varieties. International Journal of Food Properties 2013, 16, 45–60.
  • Handoussa, H.; Hanafi, R.; Eddiasty, I.; El-Gendy, M.; El Khatib, A.; Linscheid, M.; Mahran, M.; Ayoub, N. Anti-Inflammatory and Cytotoxic Activities of Dietary Phenolics Isolated from Corchorus Olitorius and Vitis Vinifera. Journal of Functional Foods 2013, 5, 1204–1216.
  • Selinsky, B.S.; Gupta, K.; Sharkey, C.T.; Loll, P.J. Structural Analysis of NSAID Binding by Prostaglandin H2 Synthase: Time-Dependent and Time-Independent Inhibitors Elicit Identical Enzyme Conformations. Biochemistry 2001, 40, 5172–5180.
  • Wang, J.L.; Limburg, D.; Graneto, M.J.; Springer, J.; Hamoer, J.R.; Liao, S.; Pawlitz, J.L.; Kurumbail, R.G.; Maziasz, T.; Talley, J.J.; Kiefer, J.R.; Carter, J. The Novel Benzopyran Class of Selective Cyclooxygenase-2 Inhibitors. Part 2: The Second Clinical Candidate Having a Shorter and Favorable Human Half-Life. Bioorganic & Medicinal Chemistry Letters 2010, 20, 7159–7163.
  • Trott, O.; Olson, A.J. AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. Journal of Computational Chemistry 2010, 31, 455–461.
  • O’Leary, K.A.; Day, A.J.; Needs, P.W.; Mellon, F.A.; O’Brien, N.M.; Williamson, G. Metabolism of Quercetin-7- and Quercetin-3-Glucuronides by An in Vitro Hepatic Model: The Role of Human Beta-Glucuronidase, Sulfotransferase, Catechol-O-Methyltransferase, and Multi-Resistant Protein 2 (MRP2) in Flavonoid Metabolism. Biochemical Pharmacology 2003, 65, 479–491.
  • Hillwig, M.L.; Hammer, K.D.; Birt, D.F.; Wurtele, E.S. Characterizing the Metabolic Fingerprint and Anti-Inflammatory Activity of Hypericum Gentianoides. Journal of Agricultural and Food Chemistry 2008, 56, 4359–4366.
  • Choi, J.H.; Kim, D.W.; Yun, N.; Choi, J.S.; Islam, M.N.; Kim, Y.S.; Lee, S.M. Protective Effects of Hyperoside Against Carbon Tetrachloride-Induced Liver Damage in Mice. Journal of Natural Products 2011, 74, 1055–1060.
  • Hiermann, A.; Schramm, H.W.; Laufer, S. Anti-Inflammatory Activity of Myricetin-3-O-Beta-D-Glucuronide and Related Compounds. Inflammation Research 1998, 47, 421–427.
  • Boeckler, F.; Ibrahim, T.; Vogel, S.; Bauer, M. Evaluation and Optimization of Virtual Screening Workflows with DEKOIS 2.0—A Public Library of Challenging Docking Benchmark Sets. Journal of Chemical Information and Modeling 2013, 53, 1447–1462.
  • Boeckler, F.M.; Ibrahim, T.M.; Vogel, S.M.; Bauer, M.R. Evaluation and Optimization of Virtual Screening Workflows with DEKOIS 2.0—A Public Library of Challenging Docking Benchmark Sets 2013, 53, 1447–1462.
  • Zarghi, A.; Arfaei, S. Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships. Iranian Journal of Pharmaceutical Research 2011, 10, 655–683.
  • Dannhardt, G.; Kiefer, W. Cyclooxygenase Inhibitors—Current Status and Future Prospects. European Journal of Medicinal Chemistry 2001, 36, 109–126.
  • Charlier, C.; Michaux, C. Dual Inhibition of Cyclooxygenase-2 (COX-2) and 5-Lipoxygenase (5-LOX) As a New Strategy to Provide Safer Non-Steroidal Anti-Inflammatory Drugs. European Journal of Medicinal Chemistry 2003, 38, 645–659.
  • Joo, Y.; Kim, J.; Kang, S.; Noh, M.; Ha, J.; Choi, J.; Lim, K.; Chung, S. 2,3-Diarylpyranon-4-Ones: A New Series of Selective Cycloxygenase-2-Inhibitors. Bioorganic & Medicinal Chemistry Letters 2004, 14, 2195–2198.
  • Chaturvedi, S.; Manivannan, M.; Prasanna, S. Quantitative Structure—Activity Relationship Analysis of a Series of 2,3-Diaryl Benzopyran Analogues As Novel Selective Cyclooxygenase-2 Inhibitors. Bioorganic & Medicinal Chemistry Letters 2004, 14, 4005–4011.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.